Menarini Group Receives Positive CHMP Opinion Recommending EC Approval of ORSERDU® (Elacestrant) for the Treatment of Patients with ER+, HER2- Locally Advanced or Metastatic Breast Cancer with an Activating ESR1 Mutation! July 23, 2023
TCL Takes the Top 2 TV Brand Spot Globally by Making Mini LED Technology Accessible to Millions March 30, 2023